Clinical Trial Update: Addition of Anlotinib Hydrochloride to the Stupp Regimen Versus the Stupp Regimen Alone for Newly Diagnosed Glioblastoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating addition of Anlotinib Hydrochloride to the Stupp regimen versus Stupp regimen alone in newly diagnosed glioblastoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Anlotinib hydrochloride (anlotinib)

Snippet

Sponsor: People's Hospital of Guangxi Zhuang Autonomous Region | Conditions: Glioblastoma | Phase 2 | Status: UNKNOWN